Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 USD | +2.06% | +17.11% | +217.60% |
05-21 | Lexaria Bioscience Secures New Hypertension, Epilepsy Patents in US; Shares Rise | MT |
05-17 | Lexaria Bioscience Corp. Announces Dosing Begins in Comprehensive GLP-1 Animal Study | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+217.60% | 51.54M | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+17.91% | 246B | |
+11.24% | 213B | |
-3.15% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Transcript : Lexaria Bioscience Corp. Presents at Benzinga Virtual Global Small Cap Conference, May-13-2021 03